Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Imatinib Mesylate in Combination With Temozolomide in Patients With Malignant Glioma

NCT00354068 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00354068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00354068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Imatinib Mesylate in Combination With Temozolomide in Patients With Malignant Glioma
Lead sponsor
Duke University
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2004
Completion date
November 30, 2008
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors